Fifth Third Bancorp Buys 37,181 Shares of Revvity Inc. $RVTY

Fifth Third Bancorp boosted its position in shares of Revvity Inc. (NYSE:RVTY) by 1,031.9% in the first quarter, Holdings Channel.com reports. The firm owned 40,784 shares of the company’s stock after acquiring an additional 37,181 shares during the period. Fifth Third Bancorp’s holdings in Revvity were worth $3,573,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of RVTY. Tudor Investment Corp ET AL acquired a new stake in Revvity in the 3rd quarter valued at approximately $15,128,000. Allspring Global Investments Holdings LLC grew its stake in shares of Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after acquiring an additional 980,142 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Revvity by 186.8% in the fourth quarter. SG Americas Securities LLC now owns 123,173 shares of the company’s stock valued at $11,917,000 after purchasing an additional 80,226 shares during the last quarter. KBC Group NV raised its holdings in shares of Revvity by 115.4% in the fourth quarter. KBC Group NV now owns 39,522 shares of the company’s stock valued at $3,824,000 after purchasing an additional 21,174 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. boosted its holdings in Revvity by 6.3% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after purchasing an additional 25,233 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Stock Performance

Shares of RVTY stock opened at $110.16 on Monday. The stock has a market cap of $12.29 billion, a P/E ratio of 52.71, a P/E/G ratio of 2.17 and a beta of 1.09. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The company has a fifty day moving average price of $103.56 and a two-hundred day moving average price of $99.17. Revvity Inc. has a one year low of $81.22 and a one year high of $118.30.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts predict that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio is currently 13.40%.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Wolfe Research began coverage on shares of Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. JPMorgan Chase & Co. decreased their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and issued a $125.00 target price on shares of Revvity in a research report on Monday, July 6th. Finally, Weiss Ratings upgraded Revvity from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Four research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Revvity presently has a consensus rating of “Hold” and an average target price of $108.92.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.